C14ORF101 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.069000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.515400E-01
Normal-vs-Stage2
2.776800E-01
Normal-vs-Stage3
5.556300E-02
Normal-vs-Stage4
5.715200E-01
Stage1-vs-Stage2
7.358600E-01
Stage1-vs-Stage3
4.576300E-02
Stage1-vs-Stage4
8.760600E-01
Stage2-vs-Stage3
5.898100E-02
Stage2-vs-Stage4
1.778800E-01
Stage3-vs-Stage4
1.164320E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.377200E-01
Normal-vs-AfricanAmerican
2.377000E-01
Normal-vs-Asian
4.481400E-01
Caucasian-vs-AfricanAmerican
2.581200E-01
Caucasian-vs-Asian
5.046800E-01
AfricanAmerican-vs-Asian
8.218200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.334600E-01
Normal-vs-Female
3.226800E-01
Male-vs-Female
2.263800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.024400E-01
Normal-vs-Age(41-60Yrs)
9.813400E-01
Normal-vs-Age(61-80Yrs)
7.321400E-01
Normal-vs-Age(81-100Yrs)
2.173800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.619600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.439200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.921200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.950190E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.122570E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.536800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.309750E-01
Normal-vs-Daily Drinker
2.360200E-01
Normal-vs-Weekly Drinker
5.704200E-01
Normal-vs-Occasional Drinker
8.297200E-01
Normal-vs-Social Drinker
6.218200E-01
Non Drinker-vs-Daily Drinker
7.126800E-01
Non Drinker-vs-Weekly Drinker
5.249200E-01
Non Drinker-vs-Occasional Drinker
2.082600E-01
Non Drinker-vs-Social Drinker
1.794410E-01
Daily Drinker-vs-Weekly Drinker
4.058600E-01
Daily Drinker-vs-Occasional Drinker
1.828970E-01
Daily Drinker-vs-Social Drinker
2.027000E-01
Weekly Drinker-vs-Occasional Drinker
3.343800E-01
Weekly Drinker-vs-Social Drinker
7.691400E-01
Occasional Drinker-vs-Social Drinker
3.916800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.986000E-01
Normal-vs-Grade 2
8.841200E-01
Normal-vs-Grade 3
8.816800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.326040E-01
Grade 1-vs-Grade 3
1.306210E-01
Grade 1-vs-Grade 4
7.986000E-01
Grade 2-vs-Grade 3
9.379800E-01
Grade 2-vs-Grade 4
8.841200E-01
Grade 3-vs-Grade 4
8.816800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.288200E-01
Normal-vs-NonDiabetic
8.226400E-01
Diabetic-vs-NonDiabetic
9.384800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.159900E-02
Normal-vs-NoPancreatitis
8.571600E-01
Pancreatitis-vs-NoPancreatitis
4.586400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.667000E-01
Normal-vs-N1
2.850400E-01
N0-vs-N1
3.521200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.737000E-01
Normal-vs-TP53-NonMutant
8.808800E-01
TP53-Mutant-vs-TP53-NonMutant
1.562020E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
